Nonmotor symptoms in nursing home residents with Parkinson's disease: Prevalence and effect on quality of life

Journal of the American Geriatrics Society

Volumn 61, Issue 10, 2013, Pages 1714-1721

  Weerkamp, Nico J ^a,b   Tissingh, Gerrit ^a   Poels, Petra J E ^b   Zuidema, Systse U ^c   Munneke, Marten ^b   Koopmans, Raymond T C M ^b   Bloem, Bastiaan R ^b  

^a Sittard Geleen Heerlen   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

nonmotor symptoms; nursing home; Parkinson's disease; quality of life

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; AGITATION; ANXIETY DISORDER; APATHY; APPETITE DISORDER; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL FEATURE; COGNITIVE DEFECT; DELUSION; DEPRESSION; EUPHORIA; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; NURSING HOME; NURSING HOME PATIENT; PARKINSON DISEASE; PARKINSONISM; PREVALENCE; QUALITY OF LIFE; SLEEP DISORDER; URINARY URGENCY;

NONMOTOR SYMPTOMS; NURSING HOME; PARKINSON'S DISEASE; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; AGED; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MOTOR ACTIVITY; NETHERLANDS; NURSING HOMES; PARKINSON DISEASE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84885642822     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12458     Document Type: Article

References (49)

1. Lapane KL, Fernandez HH, Friedman JH,. Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities. SAGE Study Group. Pharmacotherapy 1999; 19: 1321-1327.
2. Mitchell SL, Kiely DK, Kiel DP, et al. The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease. J Am Geriatr Soc 1996; 44: 394-399.
3. Makoutonina M, Iansek R, Simpson P,. Optimizing care of residents with Parkinsonism in supervised facilities. Parkinsonism Relat Disord 2010; 16: 351-355.
4. Weerkamp NJ, Zuidema SU, Tissingh G, et al. Motor profile and drug treatment of nursing home residents with Parkinson's disease. J Am Geriatr Soc 2012; 60: 2277-2282.
5. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, et al. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 2011; 26: 399-406.
6. Chaudhuri KR, Healy DG, Schapira AH,. Non-motor symptoms of Parkinson's disease: Diagnosis and management. Lancet Neurol 2006; 5: 235-245.
7. Aarsland D, Larsen JP, Tandberg E, et al. Predictors of nursing home placement in Parkinson's disease: A population-based, prospective study. J Am Geriatr Soc 2000; 48: 938-942.
8. Shulman LM, Taback RL, Rabinstein AA, et al. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 193-197.
9. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire. Mov Disord 2010; 25: 704-709.
10. Mena MA, de Yebenes JG,. Drug-induced parkinsonism. Expert Opin Drug Saf 2006; 5: 759-771.
11. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
12. Wilkinson D, Schindler R, Schwam E, et al. Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate Alzheimer's disease. Dement Geriatr Cogn Disord 2009; 28: 244-251.
13. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord 2007; 22: 1901-1911.
14. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
15. Visser M, Leentjens AF, Marinus J, et al. Reliability and validity of the Beck Depression Inventory in patients with Parkinson's disease. Mov Disord 2006; 21: 668-672.
16. Aarsland D, Bronnick K, Alves G, et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 928-930.
17. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson's disease sleep scale: A new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 629-635.
18. Folstein MF, Folstein SE, McHugh PR,. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
19. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003; 61: 1222-1228.
20. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-1707; quiz 837.
21. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force. Mov Disord 2007; 22: 2314-2324.
22. Verbaan D, Jeukens-Visser M, Van Laar T, et al. SCOPA-cognition cutoff value for detection of Parkinson's disease dementia. Mov Disord 2011; 26: 1881-1886.
23. Marinus J, Visser M, Stiggelbout AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: The SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004; 75: 388-395.
24. Peto V, Jenkinson C, Fitzpatrick R,. PDQ-39: A review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998; 245 (Suppl 1): S10-S14.
25. Jenkinson C, Fitzpatrick R,. Cross-cultural evaluation of the short form 8-item Parkinson's Disease Questionnaire (PDQ-8): Results from America, Canada, Japan, Italy and Spain. Parkinsonism Relat Disord 2007; 13: 22-228.
26. Katsarou Z, Bostantjopoulou S, Peto V, et al. Assessing quality of life in Parkinson's disease: Can a short-form questionnaire be useful? Mov Disord 2004; 19: 308-312.
27. Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653.
28. Krishnan S, Sarma G, Sarma S, et al. Do nonmotor symptoms in Parkinson's disease differ from normal aging? Mov Disord 2011; 26: 2110-2113.
29. Trenkwalder C, Kohnen R, Hogl B, et al. Parkinson's disease sleep scale-validation of the revised version PDSS-2. Mov Disord 2011; 26: 644-652.
30. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study. Mov Disord 2006; 21: 916-923.
31. Chaplin A, Curless R, Thomson R, et al. Prevalence of lower gastrointestinal symptoms and associated consultation behaviour in a British elderly population determined by face-to-face interview. Br J Gen Pract 2000; 50: 798-802.
32. Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: An epidemiologic study of three communities. Sleep 1995; 18: 425-432.
33. Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357: 762-774.
34. Geda YE, Roberts RO, Knopman DS, et al. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: Population-based study. Arch Gen Psychiatry 2008; 65: 1193-1198.
35. Witjas T, Kaphan E, Azulay JP, et al. Nonmotor fluctuations in Parkinson's disease: Frequent and disabling. Neurology 2002; 59: 408-413.
36. Chaudhuri KR, Odin P, Antonini A, et al. Parkinson's disease: The non-motor issues. Parkinsonism Relat Disord 2011; 17: 717-723.
37. Weintraub D, Burn DJ,. Parkinson's disease: The quintessential neuropsychiatric disorder. Mov Disord 2011; 26: 1022-1031.
38. Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008; 23: 183-189; quiz 313.
39. Althaus A, Becker OA, Spottke A, et al. Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Parkinsonism Relat Disord 2008; 14: 626-632.
40. Weintraub D, Moberg PJ, Duda JE, et al. Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol 2003; 16: 178-183.
41. Aarsland D, Bronnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: Frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007; 78: 36-42.
42. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, et al. Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov Disord 2008; 23: 1889-1896.
43. Goetz CG, Stebbins GT,. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995; 45: 669-671.
44. Chaudhuri KR, Pal S, Bridgman K, et al. Achieving 24-hour control of Parkinson's disease symptoms: Use of objective measures to improve nocturnal disability. Eur Neurol 2001; 46 (Suppl 1): 3-10.
45. Trenkwalder C, Kies B, Rudzinska M, et al. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 2011; 26: 90-99.
46. Aarsland D, Andersen K, Larsen JP, et al. Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study. Arch Neurol 2003; 60: 387-392.
47. Martinez-Martin P, Benito-Leon J, Alonso F, et al. Health-related quality of life evaluation by proxy in Parkinson's disease: Approach using PDQ-8 and EuroQoL-5D. Mov Disord 2004; 19: 312-318.
48. Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011; 26 (Suppl 3): S42-S80.
49. Hely MA, Morris JG, Traficante R, et al. The Sydney Multicentre Study of Parkinson's Disease: Progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 1999; 67: 300-307.